Nolen-Doerr suggests
All research use must comply with applicable federal, state, and institutional regulations
His research-backed insights into leadership, culture, and disciplined growth are invaluable for anyone wanting to build a lasting business
In heterogeneous tumor environments, achieving selective targeting of mutant p53 cells without damaging wild-type p53-dependent normal cells is a major challenge, mainly for the following reasons: some drugs targeting mutant p53 may also be toxic to wild-type p53 cells, and the complex tumor microenvironment may affect the efficacy of drugs
Receptor desensitization is less of a concern here than intuition might suggest
A comprehensive multivitamin, vitamin B12, vitamin D, and adequate protein supplementation are recommended with both medications